List of biotechnology companies
From Wikipedia, the free encyclopedia
[edit] Top 100 Biotechnology Companies
The following is a list of the top 100 biotechnology companies ranked by revenue. The first six companies qualify for the list of the top 50 pharmaceutical companies.
Rank 2004 | Company | Country | Revenue 2004 (USD millions) | R&D 2004 (USD millions) | Net Income/ (Loss) 2004 (USD millions) | Employees 2004 |
---|---|---|---|---|---|---|
1 | Amgen | USA | 10,550.0 | 2,028.0 | 2,363.0 | 14,400 |
2 | Genentech | USA | 4,621.2 | 947.5 | 784.8 | 7,646 |
3 | Merck Serono | Switzerland | 2,458.1 | 594.3 | 496.2 | 4,902 |
4 | Biogen Idec | USA | 2,211.6 | 687.7 | 25.1 | 4,266 |
5 | Genzyme | USA | 2,201.1 | 391.8 | 86.5 | 7,000 |
6 | Chiron Corp. | USA | 1,723.4 | 431.1 | 78.9 | 5,400 |
7 | Gilead Sciences | USA | 1,324.6 | 223.6 | 449.4 | 1,654 |
8 | CSL | Australia | 1,273.4 | 70.2 | 152.4 | 8,000 |
9 | MedImmune | USA | 1,141.1 | 327.3 | -3.8 | 1,823 |
10 | Cephalon | USA | 1,015.4 | 274.0 | -73.8 | 2,173 |
11 | Millennium Pharmaceuticals | USA | 448.2 | 402.6 | -252.3 | 1,477 |
12 | Genencor International | USA | 470.4 | 75.8 | 26.8 | 1,271 |
13 | ImClone Systems | USA | 388.7 | 82.1 | 113.7 | 866 |
14 | Actelion | Switzerland | 379.7 | 109.7 | 70.2 | 850 |
15 | Celgene | USA | 377.5 | 160.9 | 52.8 | 766 |
16 | MGI Pharma | USA | 195.7 | 62.6 | -85.7 | 282 |
17 | QLT | Canada | 186.1 | 50.1 | 165.7 | 520 |
18 | Nabi Biopharmaceuticals | USA | 179.8 | 61.0 | -50.4 | 727 |
19 | AEterna Zentaris | Canada | 179.2 | 23.3 | -4.4 | 350 |
20 | Regeneron Pharmaceuticals | USA | 174.0 | 136.1 | 41.7 | 730 |
21 | Enzon Pharmaceuticals | USA | 169.6 | 34.8 | 1.9 | 359 |
22 | Ligand Pharmaceuticals | USA | 168.8 | 70.7 | n/a | n/a |
23 | Berna Biotech | Switzerland | 164.6 | 42.1 | -18.8 | 887 |
24 | Acambis | UK | 156.7 | 53.0 | 38.3 | 270 |
25 | InterMune | USA | 151.0 | 81.3 | -59.5 | 326 |
26 | Cangene | Canada | 120.5 | 19.7 | 25.0 | 600 |
27 | Vertex Pharmaceuticals | USA | 102.7 | 192.2 | -166.2 | 736 |
28 | Protein Design Labs | USA | 91.0 | 122.6 | -53.2 | 660 |
29 | Innogenetics | Belgium | 88.4 | 34.9 | -17.0 | 600 |
30 | Neurocrine Biosciences | USA | 85.2 | 115.1 | -45.8 | 385 |
31 | Transkaryotic Therapies | USA | 78.1 | 88.1 | -65.9 | 400 |
32 | Icos | USA | 74.6 | 71.8 | -198.2 | 675 |
33 | United Therapeutics | USA | 73.6 | 30.6 | 15.4 | 170 |
34 | LifeCell | USA | 61.1 | 7.9 | 7.2 | 196 |
35 | Myriad Genetics | USA | 56.6 | 50.7 | -40.6 | 511 |
36 | OSI Pharmaceuticals | USA | 42.8 | 110.4 | -260.4 | 452 |
37 | Isis Pharmaceuticals | USA | 42.6 | 118.5 | -142.9 | 303 |
38 | Bioniche Life Sciences | Canada | 41.8 | 10.5 | -6.0 | 305 |
39 | Enzo Biochem | USA | 41.6 | 8.1 | -6.2 | 238 |
40 | ID Biomedical | Canada | 41.2 | 37.3 | -30.5 | 511 |
41 | Protherics | UK | 38.4 | 6.7 | 2.3 | 219 |
42 | ViroLogic | USA | 36.8 | 7.8 | -81.8 | 250 |
43 | ZymoGenetics | USA | 35.7 | 94.3 | -88.8 | 410 |
44 | Peptech | Australia | 33.6 | 3.2 | 19.9 | 20 |
45 | Antisoma | UK | 33.1 | 30.3 | -1.1 | 63 |
46 | Carrington Laboratories | USA | 30.8 | 0.9 | 0.0 | 324 |
47 | Cell Therapeutics | USA | 29.6 | 101.1 | -252.3 | 402 |
48 | Cambridge Antibody Technology | UK | 28.6 | 79.1 | -68.4 | 281 |
49 | Crucell | The Netherlands | 28.1 | 25.5 | -26.5 | 210 |
50 | Vernalis | UK | 27.9 | 44.7 | 44.7 | 131 |
51 | Bavarian Nordic | Denmark | 27.5 | 23.3 | -8.9 | 117 |
52 | MorphoSys | Germany | 27.3 | 15.4 | 0.6 | 132 |
53 | Anika Therapeutics | USA | 26.5 | 4.1 | 11.2 | 61 |
54 | ImmunoGen | USA | 26.0 | 22.2 | -6.0 | 146 |
55 | Corixa | USA | 25.0 | 62.3 | -77.0 | 263 |
56 | AnGes MG | Japan | 24.9 | 34.0 | -14.2 | 85 |
57 | SciClone Pharmaceuticals | USA | 24.4 | 18.0 | -13.3 | 143 |
58 | Kosan Biosciences | USA | 22.9 | 40.2 | -22.1 | 136 |
59 | ViroPharma | USA | 22.4 | 16.4 | -19.5 | 36 |
60 | Agenix | Australia | 22.2 | 4.3 | -8.7 | 100 |
61 | Tanox | USA | 20.5 | 27.2 | -10.3 | 127 |
62 | CV Therapeutics | USA | 20.4 | 124.3 | -155.1 | 265 |
63 | NeuroSearch | Denmark | 20.4 | 23.5 | 0.2 | 175 |
64 | Indevus Pharmaceuticals | USA | 18.7 | 23.3 | -68.2 | 356 |
65 | BioMarin Pharmaceutical | USA | 18.6 | 49.8 | -187.4 | 359 |
66 | Dyax | USA | 16.6 | 39.4 | -33.1 | 100 |
67 | MediGene | Germany | 16.3 | 18.3 | -15.3 | 117 |
68 | Maxygen | USA | 16.3 | 53.3 | 8.3 | 230 |
69 | Abgenix | USA | 16.1 | 124.8 | -187.5 | 523 |
70 | GPC Biotech | Germany | 15.7 | 50.0 | -49.7 | 171 |
77 | Cytogen | USA | 14.6 | 3.2 | -20.5 | 89 |
72 | Genta | USA | 14.6 | 71.5 | -32.7 | 73 |
73 | Vical | USA | 14.5 | 31.2 | -23.7 | 169 |
74 | NPS Pharmaceuticals | USA | 14.2 | 143.1 | -168.3 | 356 |
75 | ML Laboratories | UK | 14.2 | 23.1 | -16.2 | 115 |
76 | Vitrolife | Sweden | 14.1 | 1.7 | 1.6 | 70 |
77 | Cerus | USA | 13.9 | 27.7 | -31.2 | 83 |
78 | Encysive Pharmaceuticals | USA | 13.8 | 58.1 | -54.7 | 117 |
79 | Arena Pharmaceuticals | USA | 13.7 | 57.7 | -58.0 | 291 |
80 | Medarex | USA | 12.5 | 122.0 | -186.5 | 435 |
81 | Amrad | Australia | 12.1 | 9.6 | -2.6 | 38 |
82 | Life Therapeutics | Australia | 12.0 | 1.5 | -7.2 | 133 |
83 | GenVec | USA | 11.9 | 23.1 | -18.9 | 111 |
84 | Medivir | Sweden | 11.6 | 26.1 | -15.1 | 126 |
85 | Cell Genesys | USA | 11.5 | 92.1 | -97.4 | 377 |
86 | Inex Pharmaceuticals | Canada | 11.2 | 20.6 | -25.9 | 62 |
87 | Inspire Pharmaceuticals | USA | 11.1 | 25.7 | -44.1 | 165 |
88 | Myogen | USA | 9.9 | 54.1 | -57.7 | 100 |
89 | Targeted Genetics | USA | 9.7 | 17.3 | -14.3 | 90 |
90 | Epimmune | USA | 9.6 | 10.9 | -3.9 | 37 |
91 | Progenics Pharmaceuticals | USA | 9.6 | 36.1 | -42.0 | 136 |
92 | Active Biotech | Sweden | 9.5 | 32.6 | -23.7 | 151 |
93 | GroPep | Australia | 9.1 | 3.1 | 0.7 | 85 |
94 | Novogen | Australia | 8.8 | 5.7 | -8.7 | 67 |
95 | Unigene Laboratories | USA | 8.4 | 10.7 | -5.9 | 61 |
96 | Vicuron Pharmaceuticals | USA | 8.4 | 68.5 | -80.0 | 216 |
97 | Xenova | UK | 8.4 | 24.0 | -23.0 | 75 |
98 | Dusa Pharmaceuticals | USA | 8.0 | 6.5 | -15.6 | 65 |
99 | Senetek | USA | 7.6 | 1.5 | 0.6 | 11 |
100 | Valentis | USA | 7.5 | 10.1 | -6.5 | 22 |
Source: Top 100 biotechnology companies, MedAdNews, July 2005